506 related articles for article (PubMed ID: 18501454)
21. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
Pepek JM; Willett CG; Wu QJ; Yoo S; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1413-9. PubMed ID: 20231064
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.
Beriwal S; Heron DE; Kim H; King G; Shogan J; Bahri S; Gerszten K; Lee J; Kelley J; Edwards RP
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1395-400. PubMed ID: 16442238
[TBL] [Abstract][Full Text] [Related]
23. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT.
Clivio A; Fogliata A; Franzetti-Pellanda A; Nicolini G; Vanetti E; Wyttenbach R; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):118-24. PubMed ID: 19181409
[TBL] [Abstract][Full Text] [Related]
24. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.
Bazan JG; Luxton G; Mok EC; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):700-6. PubMed ID: 22414279
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin JK; Lizarde J; Macedo JC; Ravera J; Tokita KM
Brachytherapy; 2010; 9(4):341-8. PubMed ID: 19853534
[TBL] [Abstract][Full Text] [Related]
26. Potential and limitations of intensity-modulated radiotherapy in anal cancer.
Vordermark D
J Clin Oncol; 2008 Feb; 26(4):688; author reply 688-9. PubMed ID: 18235135
[No Abstract] [Full Text] [Related]
27. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.
Donovan E; Bleakley N; Denholm E; Evans P; Gothard L; Hanson J; Peckitt C; Reise S; Ross G; Sharp G; Symonds-Tayler R; Tait D; Yarnold J;
Radiother Oncol; 2007 Mar; 82(3):254-64. PubMed ID: 17224195
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
[TBL] [Abstract][Full Text] [Related]
30. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation?
Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157
[TBL] [Abstract][Full Text] [Related]
31. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy and chemotherapy in the conservative treatment of carcinoma of the anal canal: survival and late morbidity in a series of 25 patients.
Gabriele AM; Rovea P; Sola B; Trotti AB; Comandone A
Anticancer Res; 1997; 17(1B):653-6. PubMed ID: 9066596
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary study of intensity-modulated radiation therapy for recurrent cervical cancer].
Zhou Q; Tang Y; Shu XL; Liu L
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):730-2. PubMed ID: 18307896
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
[TBL] [Abstract][Full Text] [Related]
36. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
[TBL] [Abstract][Full Text] [Related]
37. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
[TBL] [Abstract][Full Text] [Related]
38. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
[TBL] [Abstract][Full Text] [Related]
39. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
Rades D; Schwarz R; Todorovic M; Thurmann H; Graefen M; Walz J; Schild SE; Dunst J; Alberti W
Strahlenther Onkol; 2007 Jul; 183(7):398-402. PubMed ID: 17609874
[TBL] [Abstract][Full Text] [Related]
40. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
Fonteyne V; Villeirs G; Lumen N; De Meerleer G
Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]